Raptor Pharma (RPTP) CEO Won't Comment on Shire (SHPG) Bid Report, Calls it 'Rumor' - Bloomberg

August 17, 2016 5:43 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Raptor Pharma's (NASDAQ: RPTP) CEO Julie Smith told Bloomberg in a phone interview that the company does not comment on "speculation or rumors." Earlier Intereconomia said Shire offered to acquire the company for $800 million.

"I would characterize it as a rumor," she reportedly said.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Management Comments, Mergers and Acquisitions, Rumors

Related Entities

Definitive Agreement

Add Your Comment